Literature DB >> 24979542

Methotrexate and cyclosporine in psoriasis revisited.

Bruce E Strober1.   

Abstract

Methotrexate and cyclosporine - as monotherapy or in combination with biologics or other drugs - still have an important place in the roster of therapeutic options for patients with psoriasis. These medications are safe and effective in carefully selected patients and with careful monitoring. Contraindications are discussed. Data on efficacy and adverse effects-particularly hepatoxicity - are reviewed, and recommendations for monitoring are addressed. 2014 published by Frontline Medical Communications.

Entities:  

Keywords:  TNF; cyclosporine; methotrexate; psoriasis treatment

Mesh：

Substances：

Year:  2014        PMID： 24979542     DOI： 10.12788/j.sder.0066

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN： 1085-5629


  3 in total

1.  Contemporary treatment patterns in plaque psoriasis and psoriatic arthritis.

Authors:  Dorota Jenerowicz; Justyna Kaznowska; Paweł Bartkiewicz; Anna Sadowska-Przytocka; Marcin Szymkowiak; Zygmunt Adamski; Magdalena Czarnecka-Operacz
Journal:  Postepy Dermatol Alergol       Date:  2020-04-09       Impact factor: 1.837

2.  Comparative Study of Clinical Characteristics according to Therapeutic Efficacy and Drug Survival of Cyclosporine or Methotrexate in Psoriasis Vulgaris.

Authors:  Hyun Soo Lee; Soo Hyun Kwon; Eun-So Lee
Journal:  Ann Dermatol       Date:  2019-07-01       Impact factor: 1.444

3.  Erythrodermic flare-up of psoriasis with COVID-19 infection: A report of two cases and a comprehensive review of literature focusing on the mutual effect of psoriasis and COVID-19 on each other along with the special challenges of the pandemic.

Authors:  Elham Behrangi; Afsaneh Sadeghzadeh-Bazargan; Nastaran Salimi; Zoha Shaka; Mohammad Hosein Feyz Kazemi; Azadeh Goodarzi
Journal:  Clin Case Rep       Date:  2022-04-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.